Published: 2023 January 13

Cell Sorting Market

SKU : MD1895
180 pages
Report Summary
Table of Contents
List of Tables & Figures

Cell Sorting Market is segmented By Technology (Fluorescence-activated cell sorting, Magnetic activated cell sorting, Micro-Electromechanical Systems, Density Gradient Centrifugation, Immunodensity Cell Separation, Sedimentation, Others), By Product and Services (Cell Sorters, Cell Sorting Reagents & Consumables, Cell Sorting Services), By Application (Clinical Applications, Research Applications, Drug Discovery, Other Research Applications), By End-User (Research Institutes, Pharmaceutical & Biotechnology Companies, Hospitals and Clinical Testing Laboratories, Medical Schools and Academic Institutions), and By Region (North America, Latin America, Europe, Asia Pacific, Middle East, and Africa) – Share, Size, Outlook, and Opportunity Analysis, 2023-2030.

Cell sorting market is expected to grow at a CAGR of 7.2% during the forecast period (2023-2030). Cell sorting is a technique to separate cells based on their intracellular and extracellular properties used in various research and medicinal applications. Cell sorting instruments have advanced features and functionalities for various clinical studies.

Cell sorting market - Strategic Insights



Market CAGR


Segments Covered

By Technology, By Product and Services, By Application, By End-User, and By Region

Report Insights Covered

Competitive Landscape Analysis, Company Profile Analysis, Market Size, Share, Growth, Demand, Recent Developments, Mergers and acquisitions, New Product Launches, Growth Strategies, Revenue Analysis, and Other key insights.

Fastest Growing Region

Asia Pacific

Largest Market Share 

North America

To Get a Free Sample Click here

Market Dynamics:

Technological advancement in the instruments for cell sorting is expected to drive market growth.

For nearly 40 years, pharmaceutical companies have utilized genetically modified cells as miniature drug factories. These cells can be engineered to release chemicals that can be utilized to treat cancer and autoimmune diseases like arthritis. A new approach for quickly sorting single, living cells in a typical laboratory setup may benefit efforts to develop and produce new biologic medicines. A UCLA-led research team recently shown the capacity to choose cells based on their type and which compounds—and how much of those compounds—they secrete using minuscule, bowl-shaped hydrogel containers called "nanovials." The technique has the potential to boost basic biology studies as well. Nanovials are so small that 20 million would be required to fill a teaspoon. They can be enhanced with molecules that adhere to a cell's secretions and glow under colored light to catch specific types of cells. Because nanovials are constructed of a hydrogel—a polymer that can hold nearly 20 times its weight in water—they provide a wet environment akin to cells' natural habitats. The researchers also demonstrated the ability to detect uncommon antibody-secreting cells that bonded exclusively to a target molecule and the released antibody's DNA sequence information. That experiment, which was crucial in discovering novel antibody medicines, took only one day; standard approaches would take weeks. In addition, the researchers are presently employing nanovials to examine immune cells known as T cells, which are used in cell treatments and investigate unknown biological processes. Partillion Bioscience, a startup company, situated on the UCLA campus at CNSI's Magnify incubator, is similarly built on nanovial technology. Thus, from the above statements, the market is expected to drive market growth.


However, the high cost of devices, stringent regulations, lack of skilled personnel and lack of awareness of cell sorting technology in developing countries are some factors hindering the growth of the cell sorting market.

Industry Analysis

The cell sorting market provides in-depth analysis of the market based on various industry factors such as porter five forces, supply chain, pricing analysis etc.

Market Segment:

Fluorescence-Activated Cell Sorting (FACS) segment is expected to hold the largest market share in cell sorting market.

The fluorescence-Activated Cell Sorting (FACS) segment accounted for the largest market share in 2021. The segment benefits because it provides a fast, objective, and quantitative recording of fluorescent signals from individual cells and physical separation of cells of particular interest. Fluorescence-activated cell sorting (FACS) is a specialized flow cytometry that analyzes the fluorophore content and biomarkers on single cells and sorts them based on the desired phenotype. However, FACS is an antibody-dependent technology and is therefore limited in its clinical applications by the availability of antibodies conforming to good manufacturing practice (GMP). Therefore, it has increased the demand for fluorescence-Activated Cell Sorting (FACS) technology. Thus, from the above statements, the market segment accounted for the largest market share in the forecast period.

Geographical Analysis:

North America region holds the largest market share in the global cell sorting market

North America accounted for the largest market share in 2021. Owing to the increasing number of pharmaceutical and biotechnology companies, rising prevalence of chronic and infectious diseases, and high investments and funding in cell-based research. According to the National Health Council, chronic diseases affect approximately 133 million Americans, i.e., more than 40% of the total population of the US. By 2020, that number is projected to grow to an estimated 157 million, with 81 million having multiple conditions. Owing to the rising demand for cell sorting, the market players are undergoing product innovation with large investments in cell sorting research and development. For instance, LevitasBio announced the launch of a magnetic levitation-based cell separation technology in June 2020. The method spreads out different types of cells using magnet-induced density gradients and might be used to differentiate live cells from dead cells. Also, in June 2019, Sphere Fluidics closed an additional tranche of $2.9 million (£2.2 million), securing a total of $4.8 million (£3.7 million) in investment. The funding will be used as working capital for the Company’s Cyto-Mine Single Cell Analysis System, expand the UK facility, and enable the doubling of personnel by opening a new US Sales Office and Demo Lab in California.

Competitive Landscape:

Major key players in the cell sorting market are Thermo Fisher Scientific Inc., Becton, Dickinson and Company, Merck KGaA, Danaher Corporation, Bio-Rad Laboratories, Agilent Technologies, Inc., Olympus Corporation, STEMCELL Technologies Inc., Miltenyi Biotec, and Sysmex Partec GmbH.

Becton, Dickinson and Company:


Becton, Dickinson and Company, also known as BD, is an American multinational medical technology company that manufactures and sells medical devices, instrument systems, and reagents. BD is one of the largest global medical technology companies in the world and is advancing the world of health by improving medical discovery, diagnostics and the delivery of care.

­Product Portfolio:

BD FACSDiscover S8: The BD FACSDiscover S8 Cell Sorter combines advanced spectral flow cytometry with the novel BD CellView Image Technology, which captures images of individual cells flowing through the system and sorts them based on detailed microscopic image analysis of each one at high sort speed.

The global cell sorting market report would provide an access to an approx. 45+market data table, 40+figures and 180pages.

Trending Topics

Cell Culture Market

3D Cell Culture Market

Buy this report
Single User
Multiple User
Enterprise User
Proceed to Buy